[HTML][HTML] Update on the Use of Mesenchymal Stem Cells in the Treatment of Various Infectious Diseases Including COVID-19 Infection
KA Al-Anazi, RY Al-Ansari - Journal of Stem Cell Therapy …, 2023 - stemcelltherjournal.com
Mesenchymal Stem Cells (MSCs) have antimicrobial, anti-inflammatory, immunomodulatory,
and regenerative potentials. Additionally, utilization of MSCs in the clinical arena has been …
and regenerative potentials. Additionally, utilization of MSCs in the clinical arena has been …
[HTML][HTML] Combating COVID-19 with mesenchymal stem cell therapy
K Rajarshi, A Chatterjee, S Ray - Biotechnology reports, 2020 - Elsevier
The COVID-19 disease is caused by a positive stranded RNA virus called SARS-CoV-2. The
virus mainly targets the pulmonary epithelial cells as it's initial site of infection by letting its …
virus mainly targets the pulmonary epithelial cells as it's initial site of infection by letting its …
[HTML][HTML] Mesenchymal stem cell therapy for COVID-19
F Sengul, B Ozturk, H Vatansev - American Journal of Stem Cells, 2021 - ncbi.nlm.nih.gov
Abstract The coronavirus disease (COVID-19) caused by severe acute respiratory syndrome
coronavirus (SARS-CoV-2) started in December 2019 and affected the whole world in a …
coronavirus (SARS-CoV-2) started in December 2019 and affected the whole world in a …
Mesenchymal stem cells in SARS-CoV-2 infection: A hype or hope
COVID-19 is a serious viral infection that struck the world in December 2019 starting from
Wuhan in China, spreading subsequently to all over the world. The disease has baffled …
Wuhan in China, spreading subsequently to all over the world. The disease has baffled …
Mesenchymal stem cells: a new front emerges in coronavirus disease 2019 treatment
Currently, treating coronavirus disease 2019 (COVID-19) patients, particularly those afflicted
with severe pneumonia, is challenging, as no effective pharmacotherapy for severe acute …
with severe pneumonia, is challenging, as no effective pharmacotherapy for severe acute …
[HTML][HTML] Stem cell therapy: A promising treatment for COVID-19
ZX Zheng - World Journal of Clinical Cases, 2021 - ncbi.nlm.nih.gov
Abstract Novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic. SARS-CoV-2 is an …
syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic. SARS-CoV-2 is an …
[HTML][HTML] Mesenchymal Stem Cells in the Treatment of COVID-19
BC Guo, KH Wu, CY Chen, WY Lin, YJ Chang… - International Journal of …, 2023 - mdpi.com
Since the emergence of the coronavirus disease 2019 (COVID-19) pandemic, many lives
have been tragically lost to severe infections. The COVID-19 impact extends beyond the …
have been tragically lost to severe infections. The COVID-19 impact extends beyond the …
[HTML][HTML] The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019
MA Canham, JDM Campbell, JC Mountford - Journal of Translational …, 2020 - Springer
More than seven months into the coronavirus disease-19 (COVID-19) pandemic, infection
from the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to over …
from the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to over …
[HTML][HTML] Critical roles of cytokine storm and bacterial infection in patients with COVID-19: therapeutic potential of mesenchymal stem cells
The severe acute respiratory syndrome coronavirus 2 has been a shocking disaster for
healthcare systems worldwide since December 2019. This virus can affect all systems of the …
healthcare systems worldwide since December 2019. This virus can affect all systems of the …
[HTML][HTML] Mesenchymal stem cell treatment for COVID-19
R Xu, Z Feng, FS Wang - EBioMedicine, 2022 - thelancet.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has caused a
global pandemic since late 2019 that resulted in more than 360 million population infection …
global pandemic since late 2019 that resulted in more than 360 million population infection …